PharmaBio Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 11

PharmaBio General Information

Description

Developer of regenerative medical products designed to produce improved-quality final medical products and drugs from living cells and tissues. The company's products contribute to medical and social progress and challenge the developing of new drugs, enabling customers to access cell- and tissue-based medicines.

Contact Information

Website
www.pharmabio.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Life Innovation Center 2nd Floor
  • 3-25-22, Tonomachi, Kawasaki-Ku, Kawasaki-shi, Kanagawa
  • Tokyo, 210-0821
  • Japan
+81
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Life Innovation Center 2nd Floor
  • 3-25-22, Tonomachi, Kawasaki-Ku, Kawasaki-shi, Kanagawa
  • Tokyo, 210-0821
  • Japan
+81

PharmaBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 14-Jul-2025 Completed Generating Revenue
3. Later Stage VC 28-Apr-2023 Completed Generating Revenue
2. Seed Round 31-Dec-2019 $19.9M $19.9M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view PharmaBio’s complete valuation and funding history, request access »

PharmaBio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class B
Class A
To view PharmaBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

PharmaBio Patents

  • 37

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

PharmaBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023261086-A1 Method for producing cell sheet Pending 27-Apr-2022
EP-4516895-A1 Method for producing cell sheet Pending 27-Apr-2022
EP-4516895-A4 Method for producing cell sheet Pending 27-Apr-2022
US-20250290044-A1 Method for producing cell sheet Pending 27-Apr-2022
WO-2023210609-A1 Method for producing cell sheet Inactive 27-Apr-2022 C12N5/0667
To view PharmaBio’s complete patent history, request access »

PharmaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaBio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
ATHLEE (Singapore) Venture Capital Minority
Japan Venture Capital Venture Capital Minority
Nippon Venture Capital Corporate Venture Capital Minority
Pasona Group Corporation Minority
SBI Okasan Alternative Investment Asset Manager Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

PharmaBio FAQs

  • When was PharmaBio founded?

    PharmaBio was founded in 1978.

  • Where is PharmaBio headquartered?

    PharmaBio is headquartered in Tokyo, Japan.

  • What is the size of PharmaBio?

    PharmaBio has 38 total employees.

  • What industry is PharmaBio in?

    PharmaBio’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is PharmaBio a private or public company?

    PharmaBio is a Private company.

  • What is PharmaBio’s current revenue?

    The current revenue for PharmaBio is .

  • How much funding has PharmaBio raised over time?

    PharmaBio has raised $34.5M.

  • Who are PharmaBio’s investors?

    ATHLEE (Singapore), Japan Venture Capital, Nippon Venture Capital, Pasona Group, and SBI Okasan Alternative Investment are 5 of 11 investors who have invested in PharmaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process